Home

Valvular heart disease guidelines 2022

Learn How To Get Rid Of Kidney Disease & Improve Kidney Function Naturally

Kidney Disease Relief Program - Improves Your Kidney Functio

  1. 2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines
  2. AND GUIDELINES Otto et al 2020 ACC/AHA Guideline for the Management of Valvular Heart Disease: Executive Summary AIM: This executive summary of the valvular heart disease guideline provides recommendations for clinicians to diagnose and manage valvular heart disease as well as supporting documentation to encourage their use
  3. The American Heart Association requests that this document be cited as follows: Otto CM, Nishimura RA, Bonow RO, Carabello BA, Erwin JP 3rd, Gentile F, Jneid H, Krieger EV, Mack M, McLeod C, O'Gara PT, Rigolin VH, Sundt TM 3rd, Thompson A, Toly C. 2020 ACC/AHA guideline for the management of patients with valvular heart disease: executive.
  4. 2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Clinical Practice Guideline: Full Text. Writing Committee Members
  5. Disease stages in patients with valvular heart disease should be classified (Stages A, B, C, and D) on the basis of symptoms, valve anatomy, the severity of valve dysfunction, and the response of the ventricle and pulmonary circulation

The 2020 guideline for the management of patients with valvular heart disease replaces the American Heart Association/American College of Cardiology (AHA/ACC) 2014 guideline and the 2017 focused update The risk of developing IE is highest in patients with a prosthetic valve, prior IE, or congenital heart disease with residual flow disturbances. 3 IE has been reported to occur after transcatheter aortic valve implantation (TAVI) at rates equal to or exceeding those associated with surgical aortic valve replacement (SAVR) and is associated with. Otto et al 2020 ACC/AHA Guideline for the Management of Valvular Heart Disease e2 TBD TBD, 2021 Circulation. 2021;143:e00-e00. DOI: 10.1161/CIR.0000000000000923 CLINICAL STATEMENT • This slide set is adapted from the 2020 ACC/AHA Guideline for the Management of Patients with Valvular Heart Disease. Published on Dec 17, 2020, available at: Journal of the American College of Cardiology J Am Coll Cardiol

2020 ACC/AHA Guideline for the Management of Patients With

Guidelines on the management of valvular heart disease (version 2012) Eur Heart J. 2012; 33:2451-96. Crossref Medline Google Scholar; 21. Baumgartner H, Falk V, Bax JJ, et al.. 2017 ESC/EACTS guidelines for the management of valvular heart disease. Eur Heart J. 2017; 38:2739-91. Crossref Medline Google Scholar; 22. Yancy CW, Jessup M. Aim: This executive summary of the valvular heart disease guideline provides recommendations for clinicians to diagnose and manage valvular heart disease as well as supporting documentation to encourage their use. Methods: A comprehensive literature search was conducted from January 1, 2010, to March 1, 2020, encompassing studies, reviews, and other evidence conducted on human subjects that. Download PowerPoint File. Description: See Also: Guideline Hub | Valvular Heart Disease. Date: December 17, 2020 Clinical Topics: Anticoagulation Management, Cardiac Surgery, Congenital Heart Disease and Pediatric Cardiology, Invasive Cardiovascular Angiography and Intervention, Noninvasive Imaging, Valvular Heart Disease, Aortic Surgery, Cardiac Surgery and CHD and Pediatrics, Cardiac Surgery. These items break the guidelines down into easy-to-use summaries. 2020 Executive Summary. 2020 Data Supplements (.zip file) 2020 Pocket Guide. 2020 Guideline Perspectives: Part 1. 2020 Guideline Perspectives: Part 2. 2020 Guideline Perspectives: Part 3. JACC Valvular Heart Disease Hub 2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease Published: December 17, 2020 Disease stages in patients with valvular heart disease (VHD) should be classified (Stages A, B, C, and D) based on symptoms, valve anatomy, the severity of valve dysfunction, and the response of the ventricle and pulmonary circulation

To incorporate new evidence about treatments for heart valve disease, the American College of Cardiology and American Heart Association have released the 2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease. The new guideline, written by a team of experts, replaces the 2014 guideline and 2017 focused update 2020 ACC/AHA Guideline for the Management of Patients with Valvular Heart Disease was co-published in the Circulation and in the Journal of the American College of Cardiology on December 17 th, 2020 2020 ACC/AHA Guidelines. It is reasonable to use a DOAC as an alternative to a VKA in patients with AF and native aortic valve disease, tricuspid valve disease or MR, and with a CHA2DS2-VASc score of 2 or greater. Class of Recommendation 2a. Level of Evidence C. For patients with AF and native heart disease (except rheumatic mitral stenosis) or.

ESC Clinical Practice Guidelines aim to present all the relevant evidence to help physicians weigh the benefits and risks of a particular diagnostic or therapeutic procedure on Valvular Heart Disease. They should be essential in everyday clinical decision making The ACC/AHA released key updated in their recent 2020 guideline for Valvular Heart Disease, including new guidance for the treatment fo severe symptomatic aortic stenosis and trascatheter valve repair/implantation. In it's 'Top 10 Take-Home Messages', the ACC/AHA now recommends tha

2020 ACC/AHA Heart Valve Disease Guideline: Key

  1. The 2020 AHA/ACC Guideline for the Management of Patients with Valvular Heart Disease (VHD) has been eagerly anticipated. While transcatheter mitral valve procedures (TMVR) are being performed with increased frequency, transcatheter aortic valve procedures (TAVR) are now approved for use in low-risk patients
  2. 2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease. Otto, CM et al. 2020 ACC/AHA. Guideline for the Management of Patients With Valvular Heart Disease Circulation. Table 1. ACC/AHA Applying Class of Recommendation and Level of Evidence t
  3. g of.
  4. Describe key updates in the 2020 ACC/AHA guidelines for valvular heart disease. Demonstrate the importance of assessing right ventricular function in patients with tricuspid regurgitation. Recognize the importance of the mechanism of mitral regurgitation in the management of patients with mitral valve disease
  5. 2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines [PubMed Abstract] [Full Text HTML] [Full Text PDF].Circulation. 2020 Dec 17;CIR0000000000000932
  6. The 2020 American College of Cardiology/American Heart Association (ACC/AHA) Valvular Heart Disease Guidelines now incorporate TEER using MitraClip as a Class IIa recommendation for intervention for secondary MR in patients with persistent severe symptoms (New York Heart Association functional class II to IV) . It is important to consider that.

Slide Set 2020 AHA/ACC Guideline for the Management of

  1. The 2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease was prepared by a volunteer writing committee on behalf of the American College of Cardiology and the.
  2. 2020 ACC/AHA guideline for the management of patients with valvular heart disease: A report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines
  3. The 2020 ACC/AHA Guidelines for Management of Patients With Valvular Heart Disease: Highlights and Perioperative Implications J Cardiothorac Vasc Anesth . 2021 Apr 17;S1053-0770(21)00339-6. doi: 10.1053/j.jvca.2021.04.013
  4. The 2020 Guideline for the Management of Patients with Valvular Heart Disease focuses on the diagnosis and management of adult patients with valvular heart disease (VHD). This present guideline will replace both the 2014 VHD guidelines and 2017 focused update. The goal of this guideline is to provide evidence-based, contemporary recommendations.
  5. This executive summary of the valvular heart disease guideline provides recommendations for clinicians to diagnose and manage valvular heart disease
  6. On December 17, 2020, the American College of Cardiology (ACC) and the American Heart Association (AHA) announced the release of the 2020 ACC/AHA Guideline for Management of Patients With Valvular Heart Disease. 1 Cardiac Interventions Today spoke with a panel of experts in transcatheter aortic valve replacement (TAVR) to get their take on what these guidelines mean for patients and for.
  7. g of procedures, but the.

J-STAGE Advance Publication released online September 11, 2020 This document is an English version of JCS/JSCS/JATS/JSVS 2020 Guidelines on the Management of Valvular Heart Disease reported at the 84th Annual Scientific Meeting of Japanese Circulation Society performed in 2020 (Website: https://www.j-circ 2020 ACC/AHA guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation 2020: CIR0000000000000923.

The 2020 ACC/AHA Guidelines for Management of Patients With Valvular Heart Disease: Highlights and Perioperative Implications Author links open overlay panel Divyanshu Mohananey MD, MSc * Michael Aljadah MD † Aaron A.H. Smith MD * Jeremiah F. Haines DO * Sahishnu Patel DO † Pedro Villablanca MD, MSc ‡ Harish Ramakrishna MD, FACC, FESC. The 2020 American College of Cardiology/American Heart Association (ACC/AHA) Guideline for the Management of Patients With Valvular Heart Disease has been eagerly anticipated. 1 Although transcatheter mitral valve procedures are increasingly being performed, transcatheter aortic valve procedures are now approved for use in low-risk patients. This updated 2020 guideline presents a thoughtful. Heart Association (AHA) announced the release of the 2020 ACC/AHA Guideline for Management of Patients With Valvular Heart Disease.1 Cardiac Interventions Today spoke with a panel of experts in transcatheter aortic valve replacement (TAVR) to get their take on what these guidelines mean for patients and for practice December 17, 2020—The American College of Cardiology (ACC) announced the release, with the American Heart Association (AHA), of the 2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease. The guideline is available online in the Journal of the American College of Cardiology and AHA's Circulation

2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines [PubMed Abstract] [Full Text HTML] [Full Text PDF].Circulation. 2020 Dec 17;CIR0000000000000932 Writing Committee Members 2021, ' 2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines ', Journal of the American College of Cardiology, vol. 77, no. 4, pp. 450-500 2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: Many recommendations from the earlier valvular heart disease guidelines have been updated with new evidence and provides newer options for diagnosis and treatment of valvular heart disease. This summary includes only the recommendations from the full. The 2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease were published in the AHA's journal Circulation and in the Journal of the American College of Cardiology. The new clinical guidelines aim to provide evidence-based recommendations to optimise care and management of patients with valvular heart disease, and. Mark Nicholls, The Year in Cardiovascular Medicine 2020: Valvular Heart Disease, European Heart Journal, Volume 42, Issue 16, 21 April 2021, Pages 1542-1543, He was also one of the chairs of the task force for the 2017 ESC Guidelines on valvular heart disease and the 2020 guidelines on adult congenital heart disease

ASE Guidelines by Publication Date. 2021. Recommendations for the Adult Cardiac Sonographer Performing Echocardiography to Screen for Critical Congenital Heart Disease in the Newborn: From the American Society of Echocardiography, JASE, March 2021. 2020 The new 2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease published today in the AHA's flagship journal Circulation and in the Journal of the American College of.

2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease : A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. / Writing Committee Members. In: Journal of the American College of Cardiology, Vol. 77, No. 4, 02.02.2021, p. e25-e197 Valvular heart disease is when any valve in the heart has damage or is diseased. There are several causes of valve disease. The normal heart has four chambers (right and left atria, and right and left ventricles) and four valves (Figure 1). The mitral valve, also called the bicuspid valve, allows blood to flow from the left atrium to the left. AIM: This executive summary of the valvular heart disease guideline provides recommendations for clinicians to diagnose and manage valvular heart disease as well as supporting documentation to encourage their use. METHODS: A comprehensive literature search was conducted from January 1, 2010, to March 1, 2020, encompassing studies, reviews, and.

Guideline Hub Valvular Heart Disease - American College

Arq. Bras. Cardiol. 2020; 115(4): 720-775 Update Update of the Brazilian Guidelines for Valvular Heart Disease - 2020. Flavio Tarasoutchi, Marcelo Westerlund Montera, Auristela Isabel de Oliveira Ramos, Roney Orismar Sampaio, Vitor Emer Egypto Rosa, Tarso Augusto Duenhas Accorsi, Antonio de Santis, João Ricardo Cordeiro Fernandes, Lucas José Tachotti Pires, Guilherme S. Spina, Marcelo Luiz. The 2020 guidelines add or elevate several recommendations for transcatheter therapy, lower thresholds for intervention in some conditions, and provide clinicians with useful decision-making pathways, including the use of guideline-directed medical therapy, for the diagnosis and management of valvular heart disease

The 2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease was prepared by a volunteer writing committee on behalf of the American College of Cardiology and the American Heart Association Joint Committee on Clinical Practice Guidelines Just-released valvular heart disease guidelines favor transcatheter interventions for the right patient and more shared decision-making among heart teams, physicians and severe aortic stenosis patients with an eye toward types of valves and approaches, and lifetime benefits and risks. The 2020 ACC/AHA Heart Valve Disease Guidelines mark a change from the 2014 version and 2017 focused update. Epidemiological issues and risk stratification of valvular heart disease. Rheumatic heart disease is still a major cause of VHD worldwide. In this regard, a trend towards a decrease in its incidence in the Americas has been reported. Between 1990 and 2017, the burden of mortality due to rheumatic heart disease has decreased from 88.4 to 38.8. The level 1 Comprehensive Heart Valve Center is an important and new introduction to the Guideline, they note. The level 1 Center is defined by the depth and breadth of the procedures offered

Valvular Heart Disease (Guidelines 2020) - TECHmE

  1. ACC/AHA 2020 Valvular Heart Disease Guidelines on the run for #ACCEarlyCareer Cardiologist
  2. Guideline title 2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease. Developer American College of Cardiology (ACC)/American Heart Association (AHA). Release date December 17, 2020. Prior version 2017. Funding sources ACC and AHA. Target population Adults with secondary mitral regurgitation (SMR). Major recommendations and ratings.
  3. Key Implications for Clinicians in the 2020 AHA/ACC Guideline for the Management of Patients with Valvular Heart Disease In your evaluation of a patients with suspected valvular heart disease, learn the diagnostic strategies for early detection of valvular disease and appropriate long term management
  4. Highlights from the 2020 ACC/AHA guidelines on valvular heart disease. EuroIntervention 2021;16:1303-1305. DOI: 10.4244/EIJV16I16A235. 1. A.O.U. Policlinico G. Rodolico - San Marco, Catania, Italy. In recent years, the evaluation and management of patients with valvular heart disease (VHD) has changed dramatically and transcatheter therapies.

2016 Guidelines for the Management of Dyslipidemia for the Prevention of Cardiovascular Disease in the Adult. Application of GRADE and Evidence Review. Guideline. Heart Disease. 2016. CCS/CPCA Position Statement on Pulse Oximetry Screening in Newborns to Enhance Detection of Critical Congenital Heart Disease The 2020 American College of Cardiology/American Heart Association Guideline for the Management of Patients with Valvular Heart Disease was developed by those societies in conjunction with the.

Heart Valve Disease Guideline 2020 CardioSmart

Start studying Valvular Heart Disease 2020. Learn vocabulary, terms, and more with flashcards, games, and other study tools Heart Disease and Stroke Statistics — 2021 Update. The Statistical Update presents the latest data on a range of major clinical heart and circulatory disease conditions (including stroke, congenital heart disease, rhythm disorders, subclinical atherosclerosis, coronary heart disease, heart failure, valvular disease, venous disease, and peripheral artery disease) and the associated outcomes. The 2020 valvular heart disease guideline from the American College of Cardiology and the American Heart Association also highlight a change in language as well. As a clarification, we refer to.

Endoscopic Robotic Mitral Valve Repair with Percutaneous

Update on ACC/AHA Valvular Heart Disease Guidelines 2020

About Press Copyright Contact us Creators Advertise Developers Terms Privacy Policy & Safety How YouTube works Test new features Press Copyright Contact us Creators. Guidelines published in 2020. Non-St-Segment Elevation Acute Coronary Syndromes. Chairpersons: Jean-Philippe Collet and Holger Thiele. Atrial Fibrillation. Chairpersons: Tatiana Potpara and Gerhard Hindricks. Adult Congenital Heart Disease (previously Grown-Up Congenital Heart Disease) Chairpersons: Helmut Baumgartner and Julie De Backer Covering the full range of diagnosis and treatment for valvular heart disease, this award-winning reference provides the information you need for safe and effective practice.Part of the Brauwald's family of heart disease references, Valvular Heart Disease, 5th Edition, brings you fully up to date with the latest procedures, imaging modalities, basic science, diagnostic criteria, and. The Valvular Heart Disease GUIDELINES Pocket Guide is based on the latest guidelines of the American College of Cardiology and the American Heart Association and was developed with their collaboration. This practical quick-reference tool contains detailed, graded recommendations for evaluation and management of both natural and prosthetic valve disease. Included are 20 management algorithms. Guidelines Publication Schedule. ESC Clinical Practice Guidelines and scientific statements are prepared by task forces which are groups of cardiologists that meet upon request to deal with particular problems in cardiology. Published in 2020. Non-St-Segment Elevation Acute Coronary Syndromes. Atrial Fibrillation. Adult Congenital Heart Disease

Important Changes Published in the new 2020 ACC/AHA

Valvular Heart Disease -State of the Art 2020 We now have better and better interventions But if we only intervene according to guidelines CV death still occurs following AVR Persistent heart failure symptoms occu Guidelines on Managing Valvular Heart Disease Updated. By the Editors. The American College of Cardiology and the American Heart Association have updated their guidelines on managing heart valve disease in Circulation. The new guidelines provide some less-invasive alternatives to surgery, including transcatheter aortic valve implantation 2020 ACC/AHA Guidelines Announced for Heart Valve Disease Management & Treatment. By Adam Pick on December 20, 2020. As valve disease progresses from mild to moderate to severe, there may come a time that patients hear something like this from their cardiologist, After looking at your last echocardiogram, it appears the valve has gotten worse To incorporate new evidence about treatments for heart valve disease, the American College of Cardiology and American Heart Association have released the 2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease.The new guideline, written by a team of experts, replaces the 2014 guideline and 2017 focused update. 2020.

EACTS/ESC guidelines for the treatment of valvular heart disease The common guidelines of the European Society for Cardiology (ESC) and the European Association for Cardiothoracic Surgery (EACTS) for the diagnosis and treatment of heart valve disease were presented at the 2017 ESC annual meeting and were published concurrently . An update was. Circulation Journal, 2020 Volume 84 Issue 11 Pages 2037-211

In this post I link to 2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines [PubMed Abstract] [Full-Text HTML] [Full-Text PDF]. Circulation. 2021 Feb 2;143(5):e35-e71. Jump to. Table of Content Source Reference: Otto CM, et al 2020 ACC/AHA guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association joint. Perspective to 2020 AHA/ACC Guideline for the Management of Patients with Valvular Heart Disease. AHA Clinical Update - Valvular Heart Disease (PPTX - customizable) | (pdf version) Slide Set (pdf) VHD pocket guideline (for purchase) AHA News: New guidelines call for less use of surgery to treat heart valve disease 2020 ESC Clinical Practice Guidelines for the management of adult congenital heart disease. The fourth of the new ESC Guidelines presented this year are the updated guidelines for the management of congenital heart disease (CHD) in adults. 1 The Task Force was chaired by Professor Helmut Baumgartner (University Hospital Muenster, Germany) and.

The Year in Cardiovascular Medicine: Arrhythmias 2020 reviews the most relevant studies in the field of arrhythmias and pacing. The past year has shown a significant progress: landmark clinical trials in atrial fibrillation (AF) and implantable defibrillator (ICD) therapy, new guidelines, integrated care, life style and arrhythmias, His bundle pacing, risk prediction in sudden cardiac death. For more information, go directly to the guidelines by clicking the link in the reference. February 01, 2021. 0 Read Comments. The American College of Cardiology (ACC) and American Heart Association (AHA) released their updated recommendations on managing valvular heart disease in December 2020.[ 1, 2] Ten key messages are outlined below

2020 ACC/AHA Guideline for the Management of Patients With

ESC Guidelines on Valvular Heart Disease (Management of

2017 Valvular Heart Diseases; 2017 Dual Antiplatelet Therapy; 2015 Infective Endocarditis; 2014 Hypertrophic Cardiomyopathy; 2013 Cardiac Pacing and Cardiac Resynchronization Therapy Download the slide sets (ppt) 2020. Adult Congenital Heart Disease; Atrial Fibrillation; Acute Coronary Syndromes in patients presenting without Persistent ST. AIM: This executive summary of the valvular heart disease guideline provides recommendations for clinicians to diagnose and manage valvular heart disease as well as supporting documentation to encourage their use. METHODS: A comprehensive literature search was conducted from January 1, 2010, to March 1, 2020, encompassing studies, reviews, and other evidence conducted on human subjects that. 2020 ESC Guidelines for the management of adult congenital heart disease: The Task Force for the management of adult congenital heart disease of the European Society of Cardiology (ESC). Adult Congenital and Valvular Heart Disease, University Hospital Muenster, Albert Schweitzer Campus 1, Building A1, D-48149, Muenster, Germany. Tel: +49.

After careful consideration of the new 2020 AHA/ACC clinical guidelines for valvular heart disease, we have found several points concerning the recommendations for using transcatheter edge-to-edge mitral valve (MV) repair, as a treatment in the setting of functional mitral regurgitation (FMR), with which we are totally at odds Please note that the guidelines have an outstanding Executive Summary* from e37 to e71 of the PDF. *2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines [Full-Text PDF] A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Patients with Valvular Heart Disease). Circulation . 1998;98.

ACC/AHA Valvular Heart Disease Guidelines Pocket Guide & App

Nishimura RA, Otoo CM, Bonow RO et al. 2017 AHA/ACC Focused update of the 2014 AHA/ACC guideline for the management of patients with valvular heart disease. JACC. 2017; 135:1159-1195. 8 Fingerprint Dive into the research topics of '2020 ACC/AHA guideline for the management of patients with valvular heart disease: Executive summary a report of the American College of Cardiology/American Heart Association joint committee on clinical practice guidelines'. Together they form a unique fingerprint. Sort b Nursing Intervention for Valvular Heart Disease or Valvular Heart Disease Guidelines: Nursing interventions for heart valve disease are in the below-Assess mental status (Restlessness, severe anxiety, and confusion). Check vital signs (heart rate and blood pressure). Assess heart sounds, noting gallops, S3, S4 A presentation from the When To Intervene in Valvular Heart Disease: Guidelines and New Evidence session at ESC CONGRESS 2020 - The Digital Experience In order to bring you the best possible user experience, this site uses Javascript 2020 ACC/AHA guideline for the management of patients with valvular heart disease: A report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Catherine M Otto, Rick A Nishimura, Robert O Bonow, Blase A Carabello, John P Erwin, Federico Gentile, Hani Jneid, Eric V Krieger, Michael.